DE3166682D1 - Fat emulsion containing a steroid - Google Patents

Fat emulsion containing a steroid

Info

Publication number
DE3166682D1
DE3166682D1 DE8181301931T DE3166682T DE3166682D1 DE 3166682 D1 DE3166682 D1 DE 3166682D1 DE 8181301931 T DE8181301931 T DE 8181301931T DE 3166682 T DE3166682 T DE 3166682T DE 3166682 D1 DE3166682 D1 DE 3166682D1
Authority
DE
Germany
Prior art keywords
steroid
fat emulsion
soybean oil
emulsion containing
inflammatory activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181301931T
Other languages
English (en)
Inventor
Yutaka Mizushima
Kasumasa Yokoyama
Kiichiro Nabeta
Noboru Yamada
Tadakazu Suyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13270735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3166682(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE3166682D1 publication Critical patent/DE3166682D1/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE8181301931T 1980-05-15 1981-05-01 Fat emulsion containing a steroid Expired DE3166682D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55064875A JPS609726B2 (ja) 1980-05-15 1980-05-15 ステロイド製剤

Publications (1)

Publication Number Publication Date
DE3166682D1 true DE3166682D1 (en) 1984-11-22

Family

ID=13270735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181301931T Expired DE3166682D1 (en) 1980-05-15 1981-05-01 Fat emulsion containing a steroid

Country Status (11)

Country Link
US (1) US4340594A (de)
EP (1) EP0041772B2 (de)
JP (1) JPS609726B2 (de)
KR (1) KR850001725B1 (de)
AT (1) ATE9870T1 (de)
CA (1) CA1158982A (de)
DE (1) DE3166682D1 (de)
HK (1) HK60985A (de)
IN (1) IN153855B (de)
SG (1) SG37985G (de)
ZA (1) ZA812940B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135416A (en) 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
JPS58201712A (ja) * 1982-05-18 1983-11-24 Green Cross Corp:The 脂肪乳剤
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンe↓1脂肪乳剤
JPS59152348A (ja) * 1983-02-19 1984-08-31 Kaken Pharmaceut Co Ltd ビフエニリルプロピオン酸エステル誘導体およびその製造法
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
JPS59141518A (ja) * 1983-02-03 1984-08-14 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS601122A (ja) * 1983-06-20 1985-01-07 Green Cross Corp:The ビフエニリルプロピオン酸誘導体脂肪乳剤
US4551449A (en) * 1983-11-16 1985-11-05 The Regents Of The University Of California Avoidance of the immunosuppressive and antiproliferative effects of lipid emulsions
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
SE8600632D0 (sv) * 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
JPH0794395B2 (ja) * 1986-06-16 1995-10-11 株式会社ミドリ十字 移植片の拒絶反応抑制剤
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
DE4338046A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
US5670163A (en) * 1994-06-20 1997-09-23 Kv Pharmaceuticals Company Long acting GI and esophageal protectant
JPH0827018A (ja) 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
US5554380A (en) * 1994-08-04 1996-09-10 Kv Pharmaceutical Company Bioadhesive pharmaceutical delivery system
ATE386506T1 (de) * 1995-10-17 2008-03-15 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
IL121647A (en) * 1997-08-28 2001-07-24 Pharmateam Dev Ltd Pharmaceutical compositions for the treatment of ocular inflammation comprising dexamethasone palmitate
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
WO1999040906A2 (en) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
ID29270A (id) 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
EP1214059B1 (de) * 1999-09-21 2005-05-25 Skyepharma Canada Inc. Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
CA2407027C (en) 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
ATE357216T1 (de) * 2001-02-22 2007-04-15 Jagotec Ag Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
ES2399976T3 (es) * 2006-06-01 2013-04-04 Novagali Pharma S.A. Uso de profármacos para la administración intravítrea ocular
ES2719226T3 (es) * 2007-12-04 2019-07-09 Santen Sas Composiciones que comprenden profármacos de corticosteroides tales como palmitato de dexametasona para el tratamiento de trastornos oculares
CN106727308A (zh) * 2016-12-14 2017-05-31 广东药科大学 一种地塞米松脂质乳滴眼液及其制备方法
CN116098866A (zh) * 2022-12-15 2023-05-12 中南大学湘雅医院 一种用于治疗关节痛的糖皮质激素脂肪乳、其制法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1106455B (de) * 1959-05-29 1961-05-10 Upjohn Co Salbengrundlage
US3452014A (en) * 1964-08-14 1969-06-24 Upjohn Co 2,5-dimethylpyrazine p-toluenesulfonate
JPS4524514Y1 (de) * 1965-10-15 1970-09-26
FR8028M (de) * 1967-03-01 1970-08-03
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
JPS5930674Y2 (ja) * 1978-05-02 1984-09-01 ヤンマー農機株式会社 脱穀機の揺動選別装置
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤

Also Published As

Publication number Publication date
HK60985A (en) 1985-08-23
EP0041772A2 (de) 1981-12-16
JPS56167616A (en) 1981-12-23
EP0041772B2 (de) 1990-04-18
KR850001725B1 (ko) 1985-12-07
JPS609726B2 (ja) 1985-03-12
ZA812940B (en) 1982-05-26
EP0041772A3 (en) 1982-06-30
SG37985G (en) 1985-11-15
EP0041772B1 (de) 1984-10-17
ATE9870T1 (de) 1984-11-15
CA1158982A (en) 1983-12-20
KR830005851A (ko) 1983-09-14
US4340594A (en) 1982-07-20
IN153855B (de) 1984-08-25

Similar Documents

Publication Publication Date Title
DE3166682D1 (en) Fat emulsion containing a steroid
AU1209883A (en) Extraocular methof of treating the eye with liquid perfluorocarbons
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
GR3007272T3 (de)
AU8455091A (en) Edible fats and oils stabilized with sesame oil as a constituent
NO951639D0 (no) 1<alfa>,24-(OH)2-vitamin D3-emulsjonspreparat
IT1208480B (it) Agente per intensificare l'azione antitumorale di un agente antitumorale.
DE69319338D1 (de) Einfach ungesättigte fette als nahrungszusätze zur minimierung der folgen katabolischer erkrankungen
SE7908929L (sv) Fettemulsion for intravenos injektion
DE3361768D1 (en) Phospholipid solutions
IT1123508B (it) Procedimento per l'innesto di particelle di gomma dienica in emulsione
Gilbert The effect of oestrogen and thyroxine on the blood volume of the domestic cock
EP0254845A3 (de) Immun-Stimulation mit Chondroitin-sulfat
FR2532309B1 (fr) Perfluorocycloamines et preparation d'emulsions therapeutiques contenant ces perfluorocycloamines
ES522737A0 (es) "procedimiento para la preparacion de un agente para suavizar generos textiles"
IT1092070B (it) Valvola per l'erogazione separata di due componenti e per la loro miscelazione all'esterno della stessa
ATE15604T1 (de) Biostimulierendes mittel.
ES2027446T3 (es) Composiciones que contienen grasas que tienen un bajo contenido en fosfatidos.
JPS55127318A (en) Emulsifier composition
JPS5283911A (en) Fat emulsion for intravenous injection
BE901206A (fr) Emulsion pour transfusion.
Dean The onset of metabolic acidosis and the optimal speeds of walking and running
Middleton Sexual apartheid, or androgyny? Four contemporary perspectives on women and education in New Zealand.
Kearney The Study of Women: Enlarging Perspectives of Social Reality
Rubanovsky Bachmann, A. Significance of antigen-Vi in the protective properties of typhoid serum."(Comptes Rendus des S. de la S. de Biologie, t. CXXIV, 4, 1937, p. 380)

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
V448 Application of spc

Free format text: PRODUCT NAME: DEXAMETHASON-21-PALMITAT; REGISTRATION NO/DATE: 8509.00.00, 19900928

Spc suppl protection certif: 193 75 101

Filing date: 19930701

V457 Spc granted

Free format text: PRODUCT NAME: DEXAMETHASON-21-PALMITAT; REGISTRATION NO/DATE: 8509.00.00, 19900928

Spc suppl protection certif: 193 75 101

Filing date: 19930701

8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

V464 Spc expired

Free format text: PRODUCT NAME: DEXAMETHASON-21-PALMITAT; REGISTRATION NO/DATE: 8509.00.00, 19900928

Spc suppl protection certif: 193 75 101

Filing date: 19930701